Improving management of type 2 diabetes mellitus: 5. Thiazolidinediones.
Samraj
G P
GP
Department of Community Health and Family Practice, University of Florida College of Medicine, Gainesville, USA.
Kuritzky
L
L
Quillen
D M
DM
D002839:Chromans / Q000494:pharmacology / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D004338:Drug Combinations; D004347:Drug Interactions; D016903:Drug Monitoring; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008111:Liver Function Tests; D018579:Patient Selection; D000077205:Pioglitazone; D000077154:Rosiglitazone; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use*; D045162:Thiazolidinediones; D017211:Treatment Failure; D000077288:Troglitazone
D002839:Chromans; D004338:Drug Combinations; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077288:Troglitazone; D000077205:Pioglitazone